...and just to add:
SDV potential revenues could easily multiply - all it would take is the exponential demand to really come on strong in a few years, combined with scalable, modular plant design. Perfectly reasonable to expect this imo; 50ktpa is a real possibility, instead of the 25ktpa as per the DFS baseline.
- Forums
- ASX - By Stock
- GXY
- Ann: Quarterly Report - March 2018
Ann: Quarterly Report - March 2018, page-177
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GXY (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online